Today's Pre-Market Stock Movers: BMY, ADBE, MSTR, AZN and More

$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, $I-Mab (IMAB.US)$ +2.3%, $Puma Biotechnology (PBYI.US)$ +1.8%, $AstraZeneca (AZN.US)$ +1.1%, $BeiGene (BGNE.US)$+0.8%.

$Spectrum Pharmaceuticals (SPPI.US)$ +15.8% (receives FDA approval for R.OLVEDON injection; expects to launch product in Q4)

$XL Fleet (XL.US)$ +5.1% (completes transformational acquisition of Spruce Power)

$Enthusiast Gaming (EGLX.US)$ +4.7% (signed a media sponsorship deal with Hulu + Live TV the premium streaming destination as the first official media sponsor of NFL Tuesday Night Gaming)

$Centessa Pharmaceuticals (CNTA.US)$ +4.5% (Announces Non-Human Primate Pharmacokinetic and Safety Data for LB101)

$Fortuna Silver Mines (FSM.US)$ +2.8% (extends gold mineralization at Sunbird and identifies new regional prospects at Sgula)

$ACADIA Pharmaceuticals (ACAD.US)$ +2.6% (receives acceptance from FDA for NDA of Trofinetide)

$Occidental Petroleum (OXY.US)$ +1.7% (Berkshire Hathaway discloses 26.8% stake up from 20.28% previously)

$Life Time (LTH.US)$ +1.4% (closes on $200 million in sale-leaseback transactions)

$Chicken Soup for the Soul Entertainment (CSSE.US)$ +1% (files for 7745453 share common stock offering by selling shareholders relates to warrants)

$Apexigen (APGN.US)$ -8%, $Lyell Immunopharma (LYEL.US)$ -4.9%, $Amgen (AMGN.US)$ -4%, $ImmunoGen (IMGN.US)$ -2%

$Relay Therapeutics (RLAY.US)$ -8% (announces underwritten offering of $300 mln in common stock)

$Vroom (VRM.US)$ -2.8% (files for $300 mln mixed securities shelf offering)

$Madison Square Garden Sports (MSGS.US)$ -2.4% (President and CEO to step down at end of year; also names David Hopkinson as COOZ effective immediately)

$A10 Networks (ATEN.US)$ -2.3% (purchased an aggregate of 3.5 mln of its shares from Summit)

$Allakos (ALLK.US)$ -2.2% (Initiation of Phase 2b Clinical Trial of Subcutaneous Lirentelimab in Chronic Spontaneous Urticaria)